DXCM [@Medical/Nursing Services] is valued at $33.17B. GKOS’s [@Medical/Nursing Services] market capitalization is $10.47B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $187.45B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 2 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

DXCM’s FA Score: 2 green, 3 red.
GKOS’s FA Score: 0 green, 5 red.

According to our system of comparison, GKOS is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 3 TA indicator(s) are bullish while GKOS’s TA Score has 3 bullish TA indicator(s).

DXCM’s TA Score: 3 bullish, 5 bearish.
GKOS’s TA Score: 3 bullish, 5 bearish.

According to our system of comparison, both DXCM and GKOS are a bad buy in the short-term.

Price Growth

DXCM (@Medical/Nursing Services) experienced а -3.22% price change this week, while GKOS (@Medical/Nursing Services) price change was -1.33% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.20%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -5.15%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 22, 2026.

GKOS is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.20% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES

FUNDAMENTALS

Fundamentals

DXCM($33.2B) has a higher market cap than GKOS($10.5B). GKOS YTD gains are higher at: 59.729 vs. DXCM (32.439). DXCM has higher annual earnings (EBITDA): 1.56B vs. GKOS (-141.49M). DXCM has more cash in the bank: 1.95B vs. GKOS (286M). GKOS has less debt than DXCM: GKOS (103M) vs DXCM (1.4B). DXCM has higher revenues than GKOS: DXCM (4.97B) vs GKOS (613M).

	DXCM	GKOS	DXCM / GKOS
Capitalization	33.2B	10.5B	316%
EBITDA	1.56B	-141.49M	-1,102%
Gain YTD	32.439	59.729	54%
P/E Ratio	34.74	N/A	-
Revenue	4.97B	613M	811%
Total Cash	1.95B	286M	681%
Total Debt	1.4B	103M	1,357%

FUNDAMENTALS RATINGS

DXCM vs GKOS: Fundamental Ratings

	DXCM	GKOS
OUTLOOK RATING 1..100	39	89
VALUATION overvalued / fair valued / undervalued 1..100	82 Overvalued	95 Overvalued
PROFIT vs RISK RATING 1..100	100	33
SMR RATING 1..100	25	97
PRICE GROWTH RATING 1..100	21	36
P/E GROWTH RATING 1..100	86	54
SEASONALITY SCORE 1..100	50	85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (82) in the Medical Specialties industry is in the same range as GKOS (95). This means that DXCM’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (33) in the Medical Specialties industry is significantly better than the same rating for DXCM (100). This means that GKOS’s stock grew significantly faster than DXCM’s over the last 12 months.

DXCM's SMR Rating (25) in the Medical Specialties industry is significantly better than the same rating for GKOS (97). This means that DXCM’s stock grew significantly faster than GKOS’s over the last 12 months.

DXCM's Price Growth Rating (21) in the Medical Specialties industry is in the same range as GKOS (36). This means that DXCM’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (54) in the Medical Specialties industry is in the same range as DXCM (86). This means that GKOS’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	DXCM	GKOS
RSI ODDS (%)	2 days ago 71%	2 days ago 61%
Stochastic ODDS (%)	2 days ago 71%	2 days ago 85%
Momentum ODDS (%)	2 days ago 71%	2 days ago 69%
MACD ODDS (%)	2 days ago 72%	2 days ago 69%
TrendWeek ODDS (%)	2 days ago 68%	2 days ago 71%
TrendMonth ODDS (%)	2 days ago 72%	2 days ago 79%
Advances ODDS (%)	5 days ago 69%	2 days ago 78%
Declines ODDS (%)	3 days ago 72%	4 days ago 68%
BollingerBands ODDS (%)	4 days ago 73%	3 days ago 69%
Aroon ODDS (%)	2 days ago 65%	2 days ago 78%